Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 663
Selected: 0
NCT IDTitle
NCT00845988Metabolic Effects of Switching to Aripiprazole in Patients With Bipolar Disorders
NCT01360866Safety and Tolerability of Oral OPC-34712 as Adjunctive Therapy in Adults With Major Depressive Disorder (the Orion Trial)
NCT01623154POCone-UBiT-IR300 Pediatric Comparison Study
NCT00002129A Phase I Study of Three Doses of OPC-8212 (Vesnarinone) in HIV-Infected Persons With CD4+ Cell Number > 300 Cells/mm3
NCT01509053Open-label Study to Compare Hospitalization Rates of Schizophrenic Patients Treated With Oral Antipsychotics Versus IM Depot Aripiprazole
NCT00272454Cilostazol in Acute Ischemic Stroke Treatment (CAIST)
NCT01932203Efficacy Study of Cilostazol and Aspirin on Cerebral Small Vessel Disease
NCT02538016TCUPS- Tolvaptan Use in Cystinuria and Urolithiasis: A Pilot Study
NCT02934932A Pilot Dose-Response Biomarker Study of Brexpiprazole Treatment in PTSD
NCT03257865A Trial to Assess Brexpiprazole Versus Placebo for the Treatment of Acute Manic Episodes, Associated With Bipolar I Disorder
NCT04244253A Phase 2 Trial of OPC-64005 for Major Depressive Disorder
NCT00130039Trial of Cilostazol in Symptomatic Intracranial Arterial Stenosis II
NCT02105285Efficacy and Safety Study of OPC-1085EL Ophthalmic Solution in Subjects With Glaucoma or Ocular Hypertension
NCT02968121Safety and Tolerability Study of Single-dose Administration of Brexpiprazole in Adult Subjects With Schizophrenia
NCT00606177A Multicenter, Placebo-controlled, Double-blind Investigative Extension Trial of the Safety and Efficacy of Aripiprazole in the Treatment of Patients With Bipolar Disorder Experiencing a Manic or Mixed Episode
NCT00048763Safety and Efficacy of Pletal(Cilostazol) for the Treatment of Juvenile Primary and Secondary Raynaud's Phenomenon
NCT05428033A Trial of Centanafadine Efficacy and Safety in Children With Attention-deficit/ Hyperactivity Disorder (ADHD)
NCT03179787Post-Marketing Surveillance Study of Aripiprazole in Patients With Autism
NCT01909466Safety and Tolerability Study of Aripiprazole IM Depot in Adult Subjects With Schizophrenia
NCT05683340A Confirmatory Trial of ETC-1002 in Patients With Hyper-LDL Cholesterolemia
NCT02223715Prospective Observational Study of Clostridium Difficile Infection in Asian Pacific Countries
NCT00095823A Study of Adjunctive Aripiprazole in Patients With Major Depressive Disorder
NCT02168920Aripiprazole for the Treatment of Patients With Agitation Associated With Dementia of the Alzheimer's Type
NCT03063944STAT Inhibitor OPB-111077, Decitabine and Venetoclax in Treating Patients With Acute Myeloid Leukemia That Is Refractory, Relapsed or Newly Diagnosed and Ineligible for Intensive Chemotherapy
NCT01713257Study of Arginine Free IED in Critically Ill Patients.
NCT00234065Post-marketing Study of Cilostazol (Cilostazol Stroke Prevention Study 2)
NCT02697045Effects of Aripiprazole (LAI) on Phychosocial/Cognitive Functioning, pt Reported AcceptabilityofTreatment in Sch
NCT00822172Evaluation of Cilostazol in Combination With L-Carnitine
NCT05817331Refine and Assess the Readability of Patient, Carer, and Clinician Treatment Preference in Myelodysplasia Questionnaire
NCT00237939A Study of Aripiprazole in the Management of Patients With Schizophrenia in the General Psychiatric Practices
NCT06973577P3b Short-term Study of CTN in Patients With ADHD and Comorbid Anxiety
NCT00279409Treatment of Children With ADHD Who do Not Fully Respond to Stimulants
NCT04258839Brexpiprazole in Treatment of Children and Adolescents With Irritability Associated With Autism Spectrum Disorder for Subjects That Have Completed Participation in 331-201-00148
NCT03678688A Phase 1/2 Trial of Multiple Oral Doses of OPC-167832 for Uncomplicated Pulmonary Tuberculosis
NCT00766545Cilostazol Stroke Prevention Study : A Placebo-controlled Double-blind Trial for Secondary Prevention of Cerebral Infarction.
NCT02548845An Observational Study to Describe the Adherence to the SEOM Algorithm for the Treatment of Hyponatraemia in Spain
NCT03255226Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics Study of Tolvaptan in Pediatric Congestive Heart Failure (CHF) Patients With Volume Overload
NCT00048776Safety and Efficacy of Pletal (Cilostazol) for the Treatment of Juvenile Primary and Secondary Raynaud's Phenomenon
NCT02334787A Phase 1 Trial of OPA-15406 Ointment in Healthy Adult Male Subjects
NCT01677338Phase 2 Study to Evaluate the Preliminary Performance of the C13-URA Breath Test Kit in Dyspeptic Subjects
NCT01027013Safety and Efficacy Study of Rebamipide 2% Ophthalmic Suspension in Patients With Dry Eye
NCT00041678Study of Aripiprazole in the Treatment of Patients With Psychosis Associated With Dementia of the Alzheimer's Type
NCT03197714Clinical Trial of OPB-111077 in Patients With Relapsed or Refractory Acute Myeloid Leukaemia
NCT03541447Tolvaptan-Octreotide LAR Combination in ADPKD
NCT04182958A Phase I, Open-Label Trial to Assess the Absorption, Metabolism, and Excretion of (14C)-OPC-61815 in Healthy Male Japanese Subjects
NCT04770285Trial to Evaluate the Effectiveness of a Digital Therapeutics in Adults Diagnosed With Major Depressive Disorder
NCT02472652Aripiprazole, Abilify Maintena Collaborative Clinical Protocol
NCT02237417Impact of Aripiprazole Once Monthly Medications on Changes in Brain Structure and Metabolism
NCT03605849A Trial Evaluating the Long-term Safety and Tolerability of Centanafadine Sustained-release Tablets in Adults With Attention-Deficit/Hyperactivity Disorder
NCT00413777Tolvaptan Open-label Pilot Efficacy, Tolerability, and Safety Study in Autosomal Dominant Polycystic Kidney Disease (ADPKD)